[ Price : $8.95]
FDA chooses associate commissioner for international programs Melinda Plaisier as its new Central Regional director, based in Chic...[ Price : $8.95]
An AstraZeneca-funded study shows that U.S. Hispanics have a lower awareness and understanding of atherosclerosis than of other he...[ Price : $8.95]
FDA requests safety and effectiveness information on ecamsule as a sunscreen ingredient.[ Price : $8.95]
FDA places a partial clinical hold on Cell Genesys terminated VITAL-2 GVAX prostate cancer immunotherapy program.[ Price : $8.95]
Allergan says it will file a Botox sBLA in 2009 for treating chronic migraine.[ Price : $8.95]
Genentech and Biogen Idec revise the black box warning on Rituxan after a rheumatoid arthritis patient treated with the therapy de...[ Price : $8.95]
FDA gives priority review to Novartis investigational advanced kidney cancer drug Afinitor.[ Price : $8.95]
FDA approves a Phase 2 trial of Rexahns Serdaxin for treating major depressive disorder.